Published on in Vol 2, No 1 (2016): Jan-Jun

The Effects of Physical Activity on Health and Quality of Life in Adolescent Cancer Survivors: A Systematic Review

The Effects of Physical Activity on Health and Quality of Life in Adolescent Cancer Survivors: A Systematic Review

The Effects of Physical Activity on Health and Quality of Life in Adolescent Cancer Survivors: A Systematic Review

Authors of this article:

Amanda Wurz 1 Author Orcid Image ;   Jennifer Brunet 1 Author Orcid Image

Original Paper

School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada

Corresponding Author:

Jennifer Brunet, PhD

School of Human Kinetics

Faculty of Health Sciences

University of Ottawa

Montpetit Hall, Room 339

125 University Private

Ottawa, ON, K1N 6N5


Phone: 1 613 562 5800 ext 3068

Fax:1 613 562 5497


Background: There are numerous published controlled trials assessing the safety and the benefits of physical activity (PA) for child and adult cancer survivors. However, trials exclusively comprised of adolescent cancer survivors aged 13-19 years, who may experience different health and quality of life (QOL) effects as a function of their developmental status, are lacking. Rather, some trials have included both adolescent and child cancer survivors together.

Objective: The aim of this systematic review was to synthesize the findings from randomized controlled trails (RCTs) and controlled clinical trials (CCTs) investigating the effects of PA on health and QOL outcomes in samples comprised of >50% adolescent cancer survivors to summarize the current state of evidence, identify knowledge gaps, and highlight areas in need of additional research within this population.

Methods: Using a search strategy developed for this review, 10 electronic databases were searched for RCTs and CCTs that reported on the effects of PA on at least 1 health and/or QOL outcome in samples comprised of >50% adolescent cancer survivors.

Results: From the 2249 articles identified, 2 CCTs met the predetermined eligibility criteria and were included in this review. Combined, 28 adolescents (of 41 participants) who were receiving active treatment participated in the 2 studies reviewed. A total of 4 health and QOL outcomes (ie, bone mass, fatigue, grip strength, QOL) were assessed pre- and post-PA intervention.

Conclusions: On the basis of the 2 studies reviewed, PA appears to be safe and feasible. PA also shows promise to mitigate reductions in bone mass and might be a viable strategy to improve fatigue, grip strength, and QOL. High-quality controlled trials with larger samples exclusively comprised of adolescent cancer survivors that assess a wide range of outcomes are needed to determine the effects of PA on health and QOL outcomes in this population.

JMIR Cancer 2016;2(1):e6



Each year in North America, more than 7500 adolescents are diagnosed with cancer [1,2], thereby becoming a “cancer survivor” as the National Cancer Institute defines a cancer survivor from the point of diagnosis onward [3]. Accordingly, a cancer survivor is a person who may be awaiting treatment, be actively receiving treatment (ie, on-treatment), or have completed treatment (ie, off-treatment). Approximately 80% of adolescents will live at least 5 years after they are diagnosed with cancer [4]. Although this rate reflects a relatively good prognosis, adolescent cancer survivors often report negative side effects (eg, fatigue, pain [5]) and have an increased risk of disability, morbidity, and premature mortality [6-10]. Furthermore, they may have impaired psychological and social functioning [11,12], which can hinder their health and quality of life (QOL [13,14]).

There have been several trials testing the effects of physical activity (PA) on health and QOL outcomes among cancer survivors [eg, 15-18], and several reviews have summarized the findings [eg, 19-22]. Combined, this work shows that PA can help to reduce the risk of disability (eg, physical limitations, neurocognitive impairments), morbidity (eg, obesity, diabetes, cardiovascular diseases, second cancers, organ dysfunctions), and premature mortality. This work also shows show that PA may decrease some of the negative side effects reported by cancer survivors, as well as improve health and QOL across different domains of functioning (ie, physical, psychological, emotional, social [15-22]). In recognition of these benefits, several cancer organizations recommend that cancer survivors incorporate PA into their daily lives [23,24], and many groups have developed PA guidelines for cancer survivors [25,26]. Notwithstanding the contributions of existing trials and reviews, none have focused exclusively on adolescent cancer survivors [15-22], preventing the development of age-appropriate PA guidelines for this population.

The Public Health Agency of Canada defines adolescents as individuals aged 13-19 years [27]. This life stage is characterized by the onset of puberty, a period when a number of biological, physical, psychological, emotional, social, and cognitive changes occur [28,29]. A diagnosis of cancer during this time may cause deviations from normative developmental changes [30]. For example, chemotherapy and radiation can result in precocious puberty, gonadal dysfunction, and infertility [31,32]. These treatments may also result in growth hormone deficiency, which has been related to decreased muscle mass, reduced PA tolerance, and impaired growth [33]. Furthermore, some of the physical challenges associated with cancer and its treatments markedly reduce PA levels [34], which may partly explain the increased odds of adolescent cancer survivors being obese by 2.59 for females and 1.86 for males compared to their siblings without a history of cancer [35]. These biological and physical challenges and changes can negatively impact adolescents’ body image and adversely affect their physical, psychological, emotional, and social functioning [36]. Thus, cancer and its treatments may affect adolescents’ psychological, social, and cognitive development, which can impair their ability to master necessary skills in these areas [37-39]. It can also lead to psychological, social, and cognitive maladjustment such as anxiety, depression, poor social relations, and lower educational and/or occupational attainment [37-39]. It is therefore imperative to determine if PA can be used as a strategy to reduce the negative effects of cancer on adolescents’ normative biological, physical, psychological, emotional, social, and cognitive development.

Given that adolescence is a time of tremendous growth and development [28,29], which can be challenged by cancer, the findings from PA trials and reviews focused on younger and older cancer survivors should be extrapolated cautiously and efforts should be made to examine the effects of PA on these outcomes in adolescent cancer survivors specifically. Hence, the aim of this systematic review of the literature was to synthesize the findings from randomized controlled trails (RCTs) and controlled clinical trials (CCTs) investigating the effects of PA on health and QOL outcomes in adolescent cancer survivors to summarize the current state of evidence in this population, identify knowledge gaps, and highlight areas in need of additional research.

The review was carried out following established criteria for the good conduct and reporting of systematic reviews (ie, Preferred Reporting Items for Systematic Review and Meta-Analyses, Cochrane Handbook for Systematic Reviews of Interventions, Consolidated Standards of Reporting Trials, Guidance on the Conduct of Narrative Synthesis in Systematic Reviews [40-45]). The full review protocol is published elsewhere [46].

Search Strategy

First, 10 electronic databases were searched (ie, CINAHL, Cochrane Central Register of Controlled Trials, EMBASE, LILACS, MEDLINE, PEDro, Physical Education Index, PsycINFO, PubMed, SPORTDiscus) for articles published in English in peer-reviewed scientific journals from database inception to November 2015. A combination of Medical Subject Heading terms and keywords covering the target population (eg, adolescent, young person, teen, cancer patient), intervention (eg, exercise, PA, physical fitness), and comparison condition (eg, control group, usual care) were used after consultation with an expert librarian (YL). Of note, these search terms were revised and refined after conducting an initial search. The rationale for this is presented in the published systematic review protocol [46], along with additional details on the specific search strategy and how it was developed. Next, the reference lists of all relevant articles identified in the electronic databases were searched to identify additional studies.

Selection of Studies

Both authors screened the titles and abstracts of all studies identified during the search using the following predetermined eligibility criteria: (1) reported the effect(s) of PA on at least 1 health and/or QOL outcome, (2) used a RCT or CCT study design, (3) had at least pre- and post-intervention assessments, and (4) had a sample comprised of >50% cancer survivors aged 13-19 years. The latter criterion was based on precursory knowledge that no PA trials have been conducted with samples exclusively comprised of adolescent cancer survivors. For the purpose of this review, an intervention was considered as anything greater than 1 PA session. Studies were excluded if they had multiple program features that could be attributed to the outcomes reported or if they had insufficient details on the target population, intervention, comparison condition, and/or outcomes (after the study authors were contacted by email and it was determined that the requested data were unavailable). The inter-rater agreement between both authors on the eligibility of studies was >95%, representing a high level of agreement [47]. In instances of disagreement during the review process, consensus was reached through discussion with 2 independent researchers (AJ and CO).

Data Extraction

Both authors extracted the following information from the eligible articles: (1) study characteristics (ie, year of publication, country, study design), (2) sample characteristics (ie, number of participants randomized, age, type(s) of cancer diagnosed, treatment status), (3) intervention characteristics (ie, supervision, setting, length, frequency, duration, intensity, activity types(s)), (4) outcome measures, and (5) outcomes (ie, health, QOL). Additional relevant information such as the use of theory and whether intention-to-treat analysis was performed were also recorded. In cases where details were missing, authors were contacted by email.

As illustrated in Figure 1, a total of 2249 articles were identified during the search, of which 2219 were from the electronic search and 30 were from the manual screening of reference lists. After 484 duplicates and 1727 articles that did not meet eligibility criteria were excluded, 38 full-text articles were considered potentially relevant. Both authors independently reviewed the full-text articles and determined that 36 studies were not eligible for review for the following reasons: study was not published in English (n=1), no full-text was available (n=12), no control group (n=3), no PA intervention (n=6), multiple program features (n=1), protocol article (n=2), no health and/or QOL outcome reported (n=1), and age criteria not met (n=10). For those studies that were excluded because of the age criteria, participants were either above the defined age range [48-55] or samples were comprised of ≤50% adolescents [56,57]. This left 2 articles that met the predetermined eligibility criteria [58,59].

Figure 1. Flow chart of search results.
View this figure

Study Characteristics

Multimedia Appendix 1 provides an overview of the characteristics of the reviewed studies. Müller et al [58] published their CCT in 2014 and Rosenhagen et al [59] published their CCT in 2011. Both studies were conducted in Germany [58,59].

Sample Characteristics

There were a total of 41 participants between the 2 studies. Müller et al [58] included 21 participants (mean age = 14.0 years; 67% (ie, 14 of 21) were aged 13-19 years), who were diagnosed with malignant bone tumors in the lower extremity and were currently receiving adjuvant treatment. Rosenhagen et al [59] included 20 participants (mean age = 15.3 years; 70% (ie, 14 of 20) were aged 13-19 years), diagnosed with mixed cancer during the isolation phase of peripheral blood stem cell transplant.

Intervention Characteristics

Both interventions varied considerably with regard to the type of PA intervention and reported characteristics. Thus, each intervention is described separately. Müller et al [58] delivered an in-hospital PA intervention during participants’ inpatient stay (range = 8-12 inpatient stays) over a 6-month period. PA sessions were offered from Monday to Friday. Participants who were not able to leave the ward to attend the session had the opportunity to complete the PA session in their hospital room. Participants were advised to attend the PA sessions at least every second day while admitted as an inpatient. Sessions lasted 15-45 minutes and included aerobic activity (ie, stationary bicycling, walking or jogging on the treadmill, using an elliptical trainer), strength training (ie, multiple joint exercises such as squats, lunges, rowing), balance and flexibility training, and sports games (eg, football, basketball, table tennis) at moderate-to-vigorous intensity. Borg’s Rating of Perceived Exertion Scale was used to monitor PA intensity. All sessions were supervised by 2 trained sports therapists [58].

Rosenhagen et al [59] delivered an in-hospital PA intervention during participants’ inpatient stay over a 5- to 7-week period. PA sessions were offered 3 times/week in participants’ hospital room. Sessions lasted 50 minutes and included moderate-intensity aerobic activity (ie, stationary bicycling) and strength training using barbells, balls, and participants’ own body weight (eg, squats, side steps, balancing on 1 leg). A heart rate monitor was used to ensure participants engaged in PA at the intended intensity. Trained sports therapists supervised each session [59].

Intervention Outcomes

The results of the PA interventions are presented in Multimedia Appendix 2. The 4 health and QOL outcomes that were assessed included: (1) bone mass, (2) fatigue, (3) grip strength, and (4) QOL. PA levels, intervention acceptance, intervention adherence, and adverse events were the non-health or QOL outcomes that were reported.

Health and QOL Outcomes

Müller et al [58] assessed bone mass with dual-energy X-ray absorptiometry, Lunar Prodigy System (enCore 2006, Software version 10.51.006; GE Healthcare, Madison, WI, USA). Changes analyzed using multivariate analysis of covariance showed decreases in bone mineral content (BMC), bone mineral density (BMD), and height-corrected lumbar spine Z-scores over the course of the intervention and at follow-up in both groups. Despite decreases in BMC, BMD, and height-corrected Z-scores in both groups, these declines were attenuated (nonsignificantly) in the intervention group compared with the control group. There was no significant difference between groups in BMC over the course of the intervention and at follow-up. There were significant differences in lumbar spine BMD and height-corrected lumbar spine Z-scores in the intervention group compared with the control group post-intervention; however, this difference was no longer significant at follow-up [58].

Rosenhagen et al [59] assessed fatigue and found that participants’ symptoms of fatigue improved, albeit not statistically significantly, over the course of the study for those assigned to the PA intervention. It is not possible to determine if fatigue differed between the intervention and control groups as no comparisons between groups were made [59].

Rosenhagen et al [59] assessed grip strength using a hand-held dynamometer (JAMAR; Homecraft Ltd, Kirby-in-Ashfield, Nottinghamshire, UK). On average, grip strength increased nonsignificantly from baseline to day 14, but returned to baseline levels post-intervention. It is not possible to determine if grip strength differed between the intervention and control groups as no comparisons were made between groups [59].

Rosenhagen et al [59] assessed QOL using participant reports on the German version of the KINDL and its associated oncology subscale [59,60]. Over the course of the study, participants in the intervention group reported a nonsignificant U-shaped trend in general QOL, that is, levels decreased from baseline to day 14 and then increased from day 14 to post-intervention. Cancer-specific QOL increased nonsignificantly over time in the intervention group. It is not possible to determine if general or cancer-specific QOL differed between groups as no comparisons were made between groups [59].

Other Outcomes

Müller et al [58] assessed daily PA levels using accelerometers (StepWatch 3TM Activity Monitor; Orthocare Innovations, Washington, DC, USA). Post-intervention (ie, 6 months after baseline) and follow-up (ie, 12 months after baseline) levels of PA were assessed in the intervention and control group. At post-intervention, the intervention group engaged in more PA (16.9 minutes/day) than the control group (1.7 minutes/day), and the effect size for this difference was large. Also, at follow-up, both the intervention and control group increased their levels of PA. However, the intervention group continued to engage in more PA (25.2 minutes/day) than the control group (8.0 minutes/day), and the effect size for this difference was large [58].

Rosenhagen et al [59] assessed participants’ acceptance of the intervention by asking participants to discuss their general opinion of the inpatient PA intervention during semi-structured interviews. For those assigned to the intervention group, they were asked to think about the PA intervention they participated in, whereas for those assigned to the control group, they were asked their opinion after receiving a description of the PA intervention delivered to those in the intervention group. Overall, participants in the intervention group held positive opinions, whereas the control group expressed skepticism about participating in such an intervention because of the additional burden they perceived it would have [59].

Müller et al [58] assessed adherence and operationalized it as the number of times the intervention was received (mean = 34.5 ± 8 PA sessions) out of the total amount of times the intervention was to be delivered (mean = 44.8 PA sessions). They reported an adherence rate of 77% [58]. Rosenhagen et al [59] did not report on adherence. No adverse events were reported in either of the PA interventions, leading the authors of the 2 studies included in this review to conclude that their PA interventions were safe [58,59].

Principal Findings

This systematic review summarizes the best available evidence regarding the effects of PA on health and QOL outcomes for samples comprised of >50% adolescent cancer survivors. A total of 2 CCTs were identified that had mixed samples of children and adolescents [58,59]. Although there was a lack of statistical significance for most outcomes, trends in the data show that PA may be a useful strategy to improve health and QOL in adolescent cancer survivors. Specifically, the studies found that bone mass, fatigue, grip strength, and QOL were maintained or improved in the PA intervention group. Simple inspection of mean values demonstrated that PA may confer clinically meaningful changes (ie, experienced as relevant by the participants). Indeed, researchers have suggested that the smallest change in a treatment outcome that patients would identify as important signifies a clinically meaningful effect [61].

Given the evidence that PA can improve symptoms of fatigue in adult cancer survivors [62,63], Rosenhagen et al [59] tested whether a PA intervention could improve symptoms of fatigue in child and adolescent cancer survivors. Although fatigue scores improved over the course of the intervention, the change was not statistically significant. This is in contrast to the overwhelming evidence that PA does improve symptoms of fatigue in adult cancer survivors [62,63], and the emerging evidence with samples comprised of both children and adolescents. For example, Yeh et al [57] delivered a 6-week home-based PA intervention using active video games to a sample of child and adolescent cancer survivors (ie, 32% adolescents, 7 of 22 participants).Participants reported improved mean fatigue scores in the intervention group over the course of the intervention; however, these changes did not result in statistically significant differences between the intervention and control group when intention-to-treat analysis (which considers the outcomes of all participants regardless of whether they received their assigned treatment) was used [57]. In contrast, when per-protocol analysis (which considers only the outcomes of participants who received their assigned treatment) was used, general fatigue scores were significantly different between the intervention group and the control group at 1-month follow-up [57]. Given the divergent findings both across studies and within studies depending on the analytical approach, more research is necessary to determine the efficacy of PA to improve symptoms of fatigue in adolescent cancer survivors. Furthermore, researchers should explore how improvements in symptoms of fatigue may in turn promote other positive physical and psychosocial outcomes (eg, emotional well-being, social engagement, cognitive functioning) in adolescent cancer survivors.

Although the included studies had samples comprised of 67% [58] and 70% [59] adolescents, it must be underscored that no published controlled trials examining the effects of PA in a sample exclusively comprised of adolescent cancer survivors aged 13-19 years were identified when this review was conducted. Both studies reviewed had survivors as young as 6 and 8 years. This is an important consideration that should be taken into account when interpreting the findings from the included studies. Moving forward, researchers seeking to study the effects of PA on health and/or QOL outcomes in adolescent cancer survivors could conduct trials at multiple sites to enroll larger samples of adolescents. Researchers could also consider reporting results for adolescents separately in cases where they have mixed samples that include children and/or adult cancer survivors. For example, although not reviewed herein because adolescents comprised a minority of the sample (ie, 38% adolescents, 11 of 29 participants), Hinds et al [56] separated data for the adolescent cancer survivors in their enhanced-activity intervention. However, the authors only reported the P-values for the total sample in the Results section, thereby making it difficult to determine if there were significant differences in the outcomes of interest (ie, sleep efficiency, fatigue) for adolescents.

In line with a previous systematic review conducted with pediatric cancer survivors aged 2-21 years [19,20], the reviewed studies had small sample sizes [58,59]. It is therefore plausible that the authors of the included studies did not detect statistically significant effects because they lacked sufficient statistical power. It is also possible that the intensity and duration of PA was insufficient to produce change in the outcomes assessed. In addition, given the evidence that long-term involvement in PA may be needed to affect health (ie, fatigue, strength) and QOL outcomes [64-66], the interventions may not have been long enough to affect the studied outcomes. Accordingly, it is possible that increasing the dose of PA, and offering interventions lasting longer, may yield statistically and clinically significant effects on health and QOL. Both studies included reported on the effects of PA for adolescent cancer survivors who were undergoing treatment [58,59]. Considering that treatments are associated with severe declines in physical, psychological, emotional, social, and cognitive functioning [5-14], it is conceivable that small improvements, or even maintenance, may translate into clinically important differences in health-related outcomes for this population.

The effects of PA on a wider range of health and QOL outcomes cannot be established as the CCTs included in this review focused mainly on physical health outcomes (ie, bone mass, fatigue, grip strength [58,59]). Considering that adolescence is a time of tremendous biological, physical, psychological, emotional, social, and cognitive development [28,29], it is especially important to assess outcomes in each of these areas to determine if PA can help promote optimal development for adolescent cancer survivors. For instance, biological changes (eg, impaired growth, weight gain or loss, early or delayed sexual maturation [30-35]) may lead some adolescent cancer survivors to feel physically different from their peers, heightening their experiences of body dissatisfaction, which may manifest as social anxiety, psychological distress, and avoidance of health protecting behaviors such as PA [36,67]. In addition, psychological, social, and cognitive development (eg, establishing autonomy and independence, building social skills and coping resources) may be negatively impacted by cancer and its treatments [37-39]. It is therefore necessary to determine if PA can facilitate the development of positive health behaviors, improve body image, mitigate psychosocial maladjustment (eg, anxiety, psychological distress, depression, social skills/functioning), and address cognitive limitations (eg, fine motor, visual-spatial and nonverbal skills, attention, concentration).

Although for the most part, PA was not shown to significantly affect adolescent cancer survivors’ health and QOL at the conventional 5% level of significance, it is important to balance the lack of evidence based on the reviewed CCTs with the previously mentioned limitations of each. Combined with evidence from case-series studies linking PA to improvements on various outcomes in this population (eg, [68]) and the overwhelming evidence for the benefits of PA in pediatric and adult cancer survivors [19-22], it seems prudent to recommend that adolescent cancer survivors engage in PA, especially given the lack of adverse events in the reviewed studies. Indeed, based on previous reviews with pediatric [19,20] and adult cancer survivors [21,22], the low dropout rates, high adherence to the intervention protocols, and ability to recruit participants in the studies reviewed, it can be concluded that PA is not only safe but also feasible for adolescent cancer survivors undergoing treatment. As such, health care providers may recommend PA to their patients without fear of harm, provided they take into account contraindications that would make PA potentially inadvisable for certain patients (eg, cardiopulmonary disease, neurological problems, impairments in general performance limiting mobility [25,26]). To date, few resources exist for health care providers who want more information regarding the safety and benefits of PA for adolescent cancer survivors [26]. Thus, many groups are developing resources. For example, based on the findings of this review, and recommendations from other research and resources [15-26], the authors of this manuscript are developing a PA pamphlet that health care providers may give to adolescent cancer survivors. In the meantime, health care providers can encourage adolescent cancer survivors to engage in PA. Health care providers should also take into account adolescents’ past PA behavior, current physical condition, contraindications, and PA preferences and may also consider referring adolescent cancer survivors to a PA specialist who has received training in cancer and PA.


The limitations of the current review should be taken into account. First, although the strength of conducting a systematic review is the ability to integrate and pool existing data to draw firm conclusions and determine effect sizes [69], the lack of studies and the variability in the interventions and outcomes reported in the studies reviewed prevented this. Second, publication bias was not assessed, and no attempts were made to identify unpublished studies. Third, details were missing in the studies reviewed. The authors of the studies reviewed responded to emails requesting additional information about their study; however, to facilitate systematic reviews and meta-analyses and to ensure rigor and transparency in research, researchers should adhere to existing guidelines for the conduct and reporting of trials (eg, Consolidated Standards of Reporting Trials, Transparent Reporting of Evaluations with Nonrandomized Designs [44,70]). Fourth, the search strategy used may not have identified all trials published on this topic. In an attempt to minimize this, the reference lists from previously published articles retrieved in the database search were scanned. Finally, adolescent cancer survivors were defined as individuals with cancer in their teenage years (ie, 13-19 years), which is in line with the range used by the Public Health Agency of Canada [27], other researchers [71], and an existing review of symptom clusters in adolescent oncology [12]. As a result, studies containing samples fitting different definitions or those with samples comprised of ≤50% of boys and girls aged 13-19 years were excluded.

On the basis of the current review, there is insufficient evidence available to conclude that PA affects adolescent cancer survivors’ health and QOL. The lack of RCTs and CCTs stands in stark contrast to the extant literature providing evidence for the effects of PA on health and QOL in younger [19,20] and older cancer survivors [21,22]. More high-quality research exploring the effects of PA on health and QOL outcomes in samples containing only adolescent cancer survivors is necessary because PA could offer a cost-effective, non-pharmacological, self-managed strategy to help adolescents manage the burden of cancer. To improve the quality of evidence-based medicine, studies should use RCT or CCT designs, have adequate sample sizes to detect minimal clinically important differences, and ensure intervention dosage is sufficient to elicit changes in the desired outcomes (ie, frequency, intensity, type, duration). Furthermore, studies should also assess the effects of PA on a broad range of biological, physical, psychological, emotional, social, and cognitive health outcomes. Finally, using the Physical Exercise Across the Cancer Experience framework [72] may ensure adolescents at different phases of the cancer trajectory (eg, during treatment, survivorship, palliation) are included in PA trials. This framework could not only help guide researchers seeking to examine the effects of PA across the entire cancer experience but also help answer questions about the optimal time to implement PA interventions for adolescent cancer survivors.


The authors would like to thank Müller et al [58] and Rosenhagen et al [59] for their responses to all queries as well as the authors of excluded studies who responded to information requests. The authors would like to thank Yongtao Lin (YL) for her input and advice during the development of the search strategy. They would also like to thank Allan Jiang (AJ) for his assistance with the preparation of the tables for this manuscript and assisting in instances of disagreement with study selection and Connor O’Rielly (CO) for his assistance in screening the literature and arbitration. This manuscript was prepared while Amanda Wurz (AW) was supported by a Vanier Canada Graduate scholarship and while Dr. Jennifer Brunet (JB) was supported by a Canadian Cancer Society Career Development Award in Prevention.

Authors' Contributions

AW and JB conceptualized and designed the systematic review protocol, performed the systematic literature searches, screened and selected studies, and extracted and interpreted the data. They were involved in all aspects of drafting, revising, and finalizing this manuscript. Furthermore, both approved the order of authorship.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Characteristics of the included physical activity interventions.

PDF File (Adobe PDF File), 35KB

Multimedia Appendix 2

Measures and outcome results from the included physical activity interventions.

PDF File (Adobe PDF File), 37KB

  1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics. Toronto, ON: Canadian Cancer Society; 2015.   URL: https:/​/www.​​~/​media/​​CW/​cancer%20information/​cancer%20101/​Canadian%20cancer%20statistics/​Canadian-Cancer-Statistics-2015-EN.​pdf [accessed 2015-11-26] [WebCite Cache]
  2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64(4):252-271 [FREE Full text] [CrossRef] [Medline]
  3. National Cancer Institute. Dictionary of Cancer Terms - Survivor   URL: [accessed 2016-03-16] [WebCite Cache]
  4. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014 Apr;64(2):83-103. [CrossRef] [Medline]
  5. Oeffinger KC, Hudson MM, Landier W. Survivorship: childhood cancer survivors. Prim Care 2009 Dec;36(4):743-780. [CrossRef] [Medline]
  6. Armstrong GT, Pan Z, Ness KK, Srivastava D, Robison LL. Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol 2010 Mar 1;28(7):1224-1231 [FREE Full text] [CrossRef] [Medline]
  7. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 2009 May 10;27(14):2339-2355 [FREE Full text] [CrossRef] [Medline]
  8. Mertens AC, Brand S, Ness KK, Li Z, Mitby PA, Riley A, et al. Health and well-being in adolescent survivors of early childhood cancer: a report from the Childhood Cancer Survivor Study. Psychooncology 2014 Mar;23(3):266-275 [FREE Full text] [CrossRef] [Medline]
  9. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001 Apr 18;93(8):618-629 [FREE Full text] [Medline]
  10. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013 Jun 12;309(22):2371-2381 [FREE Full text] [CrossRef] [Medline]
  11. Epelman CL. The adolescent and young adult with cancer: state of the art -- psychosocial aspects. Curr Oncol Rep 2013 Aug;15(4):325-331. [CrossRef] [Medline]
  12. Erickson JM, Macpherson CF, Ameringer S, Baggott C, Linder L, Stegenga K. Symptoms and symptom clusters in adolescents receiving cancer treatment: a review of the literature. Int J Nurs Stud 2013 Jun;50(6):847-869. [CrossRef] [Medline]
  13. Schultz KA, Ness KK, Whitton J, Recklitis C, Zebrack B, Robison LL, et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2007 Aug 20;25(24):3649-3656 [FREE Full text] [CrossRef] [Medline]
  14. Tai E, Buchanan N, Townsend J, Fairley T, Moore A, Richardson LC. Health status of adolescent and young adult cancer survivors. Cancer 2012 Oct 1;118(19):4884-4891 [FREE Full text] [CrossRef] [Medline]
  15. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010 Jan 10;28(2):340-347 [FREE Full text] [CrossRef] [Medline]
  16. Schwartz AL, Winters-Stone K. Effects of a 12-month randomized controlled trial of aerobic or resistance exercise during and following cancer treatment in women. Phys Sportsmed 2009 Oct;37(3):62-67. [CrossRef] [Medline]
  17. Gohar SF, Comito M, Price J, Marchese V. Feasibility and parent satisfaction of a physical therapy intervention program for children with acute lymphoblastic leukemia in the first 6 months of medical treatment. Pediatr Blood Cancer 2011 May;56(5):799-804. [CrossRef] [Medline]
  18. San Juan AF, Fleck SJ, Chamorro-Viña C, Maté-Muñoz JL, Moral S, Pérez M, et al. Effects of an intrahospital exercise program intervention for children with leukemia. Med Sci Sports Exerc 2007 Jan;39(1):13-21. [CrossRef] [Medline]
  19. Baumann FT, Bloch W, Beulertz J. Clinical exercise interventions in pediatric oncology: a systematic review. Pediatr Res 2013 Oct;74(4):366-374. [CrossRef] [Medline]
  20. Huang T, Ness KK. Exercise interventions in children with cancer: a review. Int J Pediatr 2011;2011:461512 [FREE Full text] [CrossRef] [Medline]
  21. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010 Jun;4(2):87-100. [CrossRef] [Medline]
  22. Sabiston CM, Brunet J. Reviewing the benefits of physical activity during cancer survivorship. American Journal of Lifestyle Medicine 2011 May 26;6(2):167-177. [CrossRef]
  23. American Cancer Society. Physical activity and the cancer patient. 2014.   URL: http:/​/www.​​treatment/​ survivorshipduringandaftertreatment/​stayingactive/​physical-activity-and-the-cancer-patient [WebCite Cache]
  24. Canadian Cancer Society. Physical activity during cancer treatment. 2016.   URL: http:/​/www.​​en/​cancer-information/​cancer-journey/​living-with-cancer/​physical-activity-during-cancer-treatment/​?region=mb [WebCite Cache]
  25. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010 Jul;42(7):1409-1426. [CrossRef] [Medline]
  26. Chamorro-Viña C, Keats M, Culos-Reed S. Pediatric oncology exercise manual, Version. Calgary, AB: Faculty of Kinesiology, University of Calgary, The Health and Wellness Lab; 2014.   URL: [WebCite Cache]
  27. Public Health Agency of Canada (PHAC). 2010. Adolescence (13-19)   URL: [accessed 2015-12-10] [WebCite Cache]
  28. Kipke M. Adolescent development and the biology of puberty: summary of a workshop on new research. Washington, D.C: National Academy Press; 1999.
  29. Sanders RA. Adolescent psychosocial, social, and cognitive development. Pediatr Rev 2013;34(8):354-359. [Medline]
  30. Shad AT, Gossai N, Bavishi S. Late effects of childhood cancer and treatment. 2015.   URL: [accessed 2015-12-10] [WebCite Cache]
  31. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2009 Jun 1;27(16):2677-2685 [FREE Full text] [CrossRef] [Medline]
  32. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2010 Jan 10;28(2):332-339 [FREE Full text] [CrossRef] [Medline]
  33. Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. J Clin Oncol 2015 Feb 10;33(5):492-500. [CrossRef] [Medline]
  34. Reilly JJ. Obesity during and after treatment for childhood cancer. Endocr Dev 2009;15:40-58. [CrossRef] [Medline]
  35. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Childhood Cancer Survivor Study. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003 Apr 1;21(7):1359-1365. [Medline]
  36. Pendley JS, Dahlquist LM, Dreyer Z. Body image and psychosocial adjustment in adolescent cancer survivors. J Pediatr Psychol 1997 Feb;22(1):29-43 [FREE Full text] [Medline]
  37. Bellizzi KM, Smith A, Schmidt S, Keegan TH, Zebrack B, Lynch CF, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer 2012 Oct 15;118(20):5155-5162 [FREE Full text] [CrossRef] [Medline]
  38. Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol 2013 Dec 10;31(35):4407-4415 [FREE Full text] [CrossRef] [Medline]
  39. Zebrack BJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer 2011 May 15;117(10 Suppl):2289-2294 [FREE Full text] [CrossRef] [Medline]
  40. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015 Jan;4:1 [FREE Full text] [CrossRef] [Medline]
  41. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009 Oct;62(10):e1-34 [FREE Full text] [CrossRef] [Medline]
  42. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009 Oct;62(10):1006-1012. [CrossRef] [Medline]
  43. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0. The Cochrane Collaboration; 2011.   URL: [WebCite Cache]
  44. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010 Mar;340:c869 [FREE Full text] [Medline]
  45. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M. Narrative Synthesis in Systematic Reviews. Lancaster: Lancaster University; 2005.   URL: [WebCite Cache]
  46. Wurz A, Brunet J. A Systematic review protocol to assess the effects of physical activity on health and quality of life outcomes in adolescent cancer survivors. JMIR Res Protoc 2016 Mar;5(1):e54 [FREE Full text] [CrossRef] [Medline]
  47. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 Mar;33(1):159-174. [Medline]
  48. Adamsen L, Andersen C, Midtgaard J, Møller T, Quist M, Rørth M. Struggling with cancer and treatment: young athletes recapture body control and identity through exercise: qualitative findings from a supervised group exercise program in cancer patients of mixed gender undergoing chemotherapy. Scand J Med Sci Sports 2009 Feb;19(1):55-66. [CrossRef] [Medline]
  49. Andersen C, Rørth M, Ejlertsen B, Stage M, Møller T, Midtgaard J, et al. The effects of a six-week supervised multimodal exercise intervention during chemotherapy on cancer-related fatigue. Eur J Oncol Nurs 2013 Jun;17(3):331-339. [CrossRef] [Medline]
  50. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 2009 Sep 20;27(27):4605-4612 [FREE Full text] [CrossRef] [Medline]
  51. Hayes SC, Davies PS, Parker TW, Bashford J, Green A. Role of a mixed type, moderate intensity exercise programme after peripheral blood stem cell transplantation. Br J Sports Med 2004 Jun;38(3):304-9; discussion 309 [FREE Full text] [Medline]
  52. May AM, Van WE, Korstjens I, Hoekstra-Weebers JE, Van Der Schans CP, Zonderland ML, et al. Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training. Acta Oncol 2008;47(5):825-834. [CrossRef] [Medline]
  53. Midtgaard J, Rorth M, Stelter R, Adamsen L. The group matters: an explorative study of group cohesion and quality of life in cancer patients participating in physical exercise intervention during treatment. Eur J Cancer Care (Engl) 2006 Mar;15(1):25-33. [CrossRef] [Medline]
  54. Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol 2005 Apr 1;23(10):2378-2388 [FREE Full text] [CrossRef] [Medline]
  55. Zimmer P, Bloch W, Schenk A, Zopf EM, Hildebrandt U, Streckmann F, et al. Exercise-induced natural killer cell activation is driven by epigenetic modifications. Int J Sports Med 2015 Jun;36(6):510-515. [CrossRef] [Medline]
  56. Hinds PS, Hockenberry M, Rai SN, Zhang L, Razzouk BI, Cremer L, et al. Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. J Pain Symptom Manage 2007 Jun;33(6):686-697. [CrossRef] [Medline]
  57. Yeh CH, Man Wai JP, Lin U, Chiang Y. A pilot study to examine the feasibility and effects of a home-based aerobic program on reducing fatigue in children with acute lymphoblastic leukemia. Cancer Nurs 2011;34(1):3-12. [CrossRef] [Medline]
  58. Müller C, Winter C, Boos J, Gosheger G, Hardes J, Vieth V, et al. Effects of an exercise intervention on bone mass in pediatric bone tumor patients. Int J Sports Med 2014 Jul;35(8):696-703. [CrossRef] [Medline]
  59. Rosenhagen A, Bernhörster M, Vogt L, Weiss B, Senn A, Arndt S, et al. Implementation of structured physical activity in the pediatric stem cell transplantation. Klin Padiatr 2011 May;223(3):147-151. [CrossRef] [Medline]
  60. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998 Jul;7(5):399-407. [Medline]
  61. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989 Dec;10(4):407-415. [Medline]
  62. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012 Jan;11:CD006145. [CrossRef] [Medline]
  63. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol) 2010 Apr;22(3):208-221. [CrossRef] [Medline]
  64. Dahab KS, McCambridge TM. Strength training in children and adolescents: raising the bar for young athletes? Sports Health 2009 May;1(3):223-226 [FREE Full text] [CrossRef] [Medline]
  65. Ferrer RA, Huedo-Medina TB, Johnson BT, Ryan S, Pescatello LS. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med 2011 Feb;41(1):32-47 [FREE Full text] [CrossRef] [Medline]
  66. Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011 Jan;20(1):123-133 [FREE Full text] [CrossRef] [Medline]
  67. Ness KK, Leisenring WM, Huang S, Hudson MM, Gurney JG, Whelan K, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2009 May 1;115(9):1984-1994 [FREE Full text] [CrossRef] [Medline]
  68. Keats MR, Culos-Reed SN. A community-based physical activity program for adolescents with cancer (project TREK): program feasibility and preliminary findings. J Pediatr Hematol Oncol 2008 Apr;30(4):272-280. [CrossRef] [Medline]
  69. Mulrow CD. Rationale for systematic reviews. BMJ 1994 Sep 3;309(6954):597-599 [FREE Full text] [Medline]
  70. Des Jarlais DC, Lyles C, Crepaz N, TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004 Mar;94(3):361-366. [Medline]
  71. Bahadur G, Hindmarsh P. Age definitions, childhood and adolescent cancers in relation to reproductive issues. Hum Reprod 2000 Jan;15(1):227 [FREE Full text] [Medline]
  72. Courneya KS, Friedenreich CM. Framework PEACE: an organizational model for examining physical exercise across the cancer experience. Ann Behav Med 2001;23(4):263-272. [Medline]

BMC: bone mineral content
BMD: bone mineral density
CCT: controlled clinical trials
PA: physical activity
QOL: quality of life
RCT: randomized controlled trial

Edited by G Eysenbach; submitted 10.12.15; peer-reviewed by J Erickson, P Puszkiewicz, S Schmidt; comments to author 24.01.16; revised version received 01.02.16; accepted 18.03.16; published 24.05.16


©Amanda Wurz, Jennifer Brunet. Originally published in JMIR Cancer (, 24.05.2016.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on, as well as this copyright and license information must be included.